PPARGC1A is involved in the progression and prognosis of different types of cancer, such as clear cell renal cell carcinoma [84], pancreatic cancer [85], breast cancer [86] and, lately, also in hepatocellular carcinoma (HCC). Here, PPARGC1A is linked to hepatocellular carcinoma.